These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 16489336

  • 1. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice.
    Holst J, Vignali KM, Burton AR, Vignali DA.
    Nat Methods; 2006 Mar; 3(3):191-7. PubMed ID: 16489336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Generation of chimeric T-cell receptor transgenes and their efficient transfer in primary mouse T lymphocytes.
    Howland LJ, Haynes NM, Darcy PK.
    Methods Mol Biol; 2010 Aug; 651():291-306. PubMed ID: 20686973
    [Abstract] [Full Text] [Related]

  • 14. A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer.
    Kieback E, Charo J, Sommermeyer D, Blankenstein T, Uckert W.
    Proc Natl Acad Sci U S A; 2008 Jan 15; 105(2):623-8. PubMed ID: 18182487
    [Abstract] [Full Text] [Related]

  • 15. Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
    Griffioen M, van Egmond HM, Barnby-Porritt H, van der Hoorn MA, Hagedoorn RS, Kester MG, Schwabe N, Willemze R, Falkenburg JH, Heemskerk MH.
    Haematologica; 2008 Oct 15; 93(10):1535-43. PubMed ID: 18768532
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H, Masli S, Sasaki S, Streilein JW, Stein-Streilein J.
    Invest Ophthalmol Vis Sci; 2006 Apr 15; 47(4):1533-42. PubMed ID: 16565389
    [Abstract] [Full Text] [Related]

  • 18. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
    Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I.
    Cancer Res; 2009 Dec 01; 69(23):9003-11. PubMed ID: 19903853
    [Abstract] [Full Text] [Related]

  • 19. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer.
    Arnold PY, Burton AR, Vignali DA.
    J Immunol; 2004 Sep 01; 173(5):3103-11. PubMed ID: 15322170
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.